for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. government stops funding for Inovio COVID-19 vaccine study

April 23 (Reuters) - Drug developer Inovio Pharmaceuticals said on Friday the U.S. government had stopped funding for a late-stage study testing its COVID-19 vaccine candidate, due to the increasing availability of authorized vaccines in the country.

Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up